ÇëÊäÈëÒªº¦×Ö
top
400-815-1117
400-815-1117
¹ÉƱ´úÂ룺688068
ÖÐ/EN
ÁÙ´²Õï¶Ï&²úÎï½â¾ö·½°¸
CLINICAL DIAGNOSIS & PRODUCT SOLUTIONS
½ºÌå½ð¼¼ÊõÔ­Àí
½ºÌå½ð£¨colloidal?gold£©¼´½ºÌå״̬µÄ½ðµ¥ÖÊ£¬ÒòΪÆäµ¥ÖÊÁ£¾¶ºÜÊÇС¿ÉÒÔÊèÉ¢ÓÚÈÜÒºÖÐÐγɽºÌ壬¹ÊÃû½ºÌå½ð¡£½ºÌå½ðµÄͨÀýÖÆ±¸ÒªÁìÊÇÓû¹Ô­¼Á»¹Ô­ÂȽðËáÀïµÄ½ðÔªËØÐγɽð½ºÌå¿ÅÁ£¡£ÕâÖÖ½ºÌå¿ÅÁ£ÔÚ¼îÐÔÇé¿öÏ´øÉϸºµçºÉ£¬¿ÉÓëÂѰ×ÖʵÄÕýµçºÉ»ùÍÅÀι̽áºÏ£¬¶ÔÂѰ׽øÐбêÖ¾£¬ÓÃÓÚºóÐøµÄ¼ì²â£¬ÈçÖÆ³É½ºÌå½ðÊÔÖ½Ìõ£¨¿¨£©½øÐÐÎïÖʵļì²â¡£
øÁªÃâÒß¼¼ÊõÔ­Àí

¢Ùʹ¿¹Ô­»ò¿¹Ìå½áºÏµ½Ä³ÖÖ¹ÌÏàÔØÌåÍâò£¬²¢±£³ÖÆäÃâÒß»îÐÔ¡£

¢Úʹ¿¹Ô­»ò¿¹ÌåÓëijÖÖøÁ¬½Ó³Éø±ê¿¹Ô­»ò¿¹Ì壬ÕâÖÖø±ê¿¹Ô­»ò¿¹Ìå¼È±£ÁôÆäÃâÒß»îÐÔ£¬ÓÖ±£ÁôøµÄ»îÐÔ¡£Ôڲⶨʱ£¬°ÑÊܼì±ê±¾£¨²â¶¨ÆäÖеĿ¹Ìå»ò¿¹Ô­£©ºÍø±ê¿¹Ô­»ò¿¹Ìå°´²îÒìµÄ²½ÖèÓë¹ÌÏàÔØÌåÍâòµÄ¿¹Ô­»ò¿¹ÌåÆð·´Ó³¡£ÓÃÏ´µÓµÄÒªÁìʹ¹ÌÏàÔØÌåÉÏÐγɵĿ¹Ô­¿¹Ì帴ºÏÎïÓëÆäËûÎïÖÊÀ뿪£¬×îºó½áºÏÔÚ¹ÌÏàÔØÌåÉϵÄøÁ¿Óë±ê±¾ÖÐÊܼìÎïÖʵÄÁ¿³ÉÒ»¶¨µÄ±ÈÀý¡£¼ÓÈëø·´Ó³µÄµ×Îïºó£¬µ×Îﱻø´ß»¯±äΪÓÐÉ«²úÎ²úÎïµÄÁ¿Óë±ê±¾ÖÐÊܼìÎïÖʵÄÁ¿Ö±½ÓÏà¹Ø£¬¹Ê¿Éƾ¾ÝÑÕÉ«·´Ó³µÄÉîdz¶Ô±»¼ìÎï½øÐж¨ÐÔ»ò¶¨Á¿·ÖÎö¡£ÓÉÓÚøµÄ´ß»¯ÆµÂʺܸߣ¬¹Ê¿É·Å´ó·´Ó³Ð§¹û£¬´Ó¶øÊ¹²â¶¨ÒªÁìµ½´ï¸ßµÄÃô¸Ð¶È¡£

¼ì²âÏîÄ¿
½ºÌå½ð¼ì²âÏîÄ¿
øÁªÃâÒß¼ì²âÏîÄ¿
NÄ©¶ËBÐÍÄÆÄòëÄǰÌ壨NT-proBNP£©
×¢²áÖ¤ºÅ£º¾©Ðµ×¢×¼20152400525ºÅ
ÐÄÔàÐÍÖ¬·¾Ëá½áºÏÂѰף¨H-FABP£©
×¢²áÖ¤ºÅ£º¾©Ðµ×¢×¼20172400143ºÅ
½µ¸ÆËØÔ­£¨PCT£©
×¢²áÖ¤ºÅ£º¾©Ðµ×¢×¼20162401109ºÅ
Ì¥¶ùÏËάÁ¬½ÓÂѰף¨fFN£©
×¢²áÖ¤ºÅ£º¾©Ðµ×¢×¼20152400611ºÅ
¿¹»·¹Ï°±ËáëÄ¿¹Ì壨anti-CCP£©
×¢²áÖ¤ºÅ£º¾©Ðµ×¢×¼20152400610ºÅ
ÒÒÐ͸ÎÑײ¡¶¾´óÂѰף¨HBV-LP£©
×¢²áÖ¤ºÅ£º¹úеע׼20163402118ºÅ
¸ß¶û»ùÌåÂѰ×73£¨GP73£©
×¢²áÖ¤ºÅ£º¹úеע׼20143401816ºÅ
¼×Ì¥ÂѰף¨AFP£©
×¢²áÖ¤ºÅ£º¹úеע׼20153401569ºÅ
Òì³£ÄýѪøԭ£¨DCP / PIVKA-¢ò£©
×¢²áÖ¤ºÅ£º¹úеע׼20173401319ºÅ
ÈËѪ½¬Ö¬ÂѰ×Á×֬øA2£¨Lp-PLA2£©
×¢²áÖ¤ºÅ£º¾©Ðµ×¢×¼20192400366ºÅ
¿¹»·¹Ï°±ËáëÄ¿¹Ì壨anti-CCP£©
×¢²áÖ¤ºÅ£º¾©Ðµ×¢×¼20152400609ºÅ
ÌÇÀ࿹ԭ153£¨CA153£©
×¢²áÖ¤ºÅ£º¹úеע׼20163400155ºÅ
ÌÇÀ࿹ԭ125£¨CA125£©
×¢²áÖ¤ºÅ£º¹úеע׼20193400625ºÅ
°©Åß¿¹Ô­£¨CEA£©
×¢²áÖ¤ºÅ£º¹úеע׼20153401568ºÅ
È˸½ØºÂѰ×4£¨HE4£©
×¢²áÖ¤ºÅ£º¹úеע׼20163400157ºÅ
ϸ°û½ÇÂѰ×19Ƭ¶Î£¨CYFRA21-1£©
×¢²áÖ¤ºÅ£º¹úеע׼20153401567ºÅ
×ÜǰÁÐÏÙÌØÒìÐÔ¿¹Ô­£¨tPSA£©
×¢²áÖ¤ºÅ£º¹úеע׼20153401570